The role of reactive oxygen metabolites in ulcerative colitis

Inflammatory Bowel Diseases

Volumn 3, Issue 4, 1997, Pages 260-264

  Dagli, Ülkü ^a,b   Balk, Mevhibe ^a   Yücel, Doǧan ^a   Ülker, Aysel ^a   Över, Hülya ^a   Saydam, Gülsevim ^a   Şahin, Burhan ^a  

^a Yüksek Ihtisas Hastanesi ^*  (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Inflammatory bowel disease; Reactive oxygen metabolites; Ulcerative colitis

Indexed keywords

EID: 0002609006     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199712000-00003     Document Type: Article

References (21)

1. Kirsner JB, Shorter RG. Recent development in "non-specific" inflammatory bowel disease. N Engl J Med 1982;306:775-84.
2. Donaldson RM. Crohn's disease. In: Slesinger MH, Fordtran JS, eds. Gastrointestinal disease. Philadelphia: Saunders, 1993:1270-92.
3. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-79.
4. Cross CE, Halliwell B, Borish ET, et al. Oxygen radicals and human disease. Ann Intern Med 1987;107:526-45.
5. Parks P, Buckley G, Granger N. Role of oxygen-derived free radicals in digestive tract disease. Surgery 1983;94:415-22.
6. Aruoma OL, Wasil M, Halliwell B, et al. The scavenging of oxidants by sulfasalazine and its metabolites: a possible contribution to their anti-inflammatory effect. Biochem Pharmacol 1987;36: 3739-42.
7. Williams JG, Hallett HB. Effect of sulfasalazine and its active metabolites, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils. Gut 1989;30:1581-7.
8. Emerit J, Loeper J, Chomette G. Superoxide dismutase in the treatment of post radiotherapeutic necrosis and of Crohn's disease. Bull Eur Physiol Pathol Respir 1981;17(suppl):287-8.
9. Ohkawa H, Obishi N, Kunio Y. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95: 351-8.
10. Yi S, Oberley WC, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
11. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation was based on myeloperoxidase activity. Gastroenterology 1984;87:1344-50.
12. Morson BC. Pathology of ulcerative colitis. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:281-95.
13. Weiss SJ. Oxygen, ischemia and inflammation. Acta Physiol Scand 1986;548(suppl):9-37.
14. Hruszkewycz AM. Lipid peroxidation and mt DNA degeneration. A hypothesis. Mutat Res 1992;275:243-8.
15. Vaca CE, Wilhelm J, Harms-Ringdahl M. Interaction of lipid peroxidation products with DNA. A review. Mutat Res 1988;195:137-49.
16. Sharon P, Stenson WF. Enhanced synthesis of leukotriene by colonic mucosa by inflammatory bowel disease. Gastroenterology 1984;86:453-60.
17. Niwa Y, Somiga K, Michelson AM, Puget K. Effect of liposomal encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Rad Res Commun 1985; 137-53.
18. Mulder TPJ, Verspaget HW, Janssens AR, et al. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991;32:1146-50.
19. Verspaget HW, Pena AS, Weterman IT, Lamers CBHW. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by oxidative metabolism and low superoxide dismutase content. Gut 1988;29:223-8.
20. Çetin S, Görgül A, Kaymakçioǧlu N, Sen D. The role of antioxidant agents on experimental ulcerative colitis. Bull Gulhane Mil Med Acad 1994;36:452-7.
21. Grisham M, Granger N. Neutrophil mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6-15.